DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

Prothena Corporation (NASDAQ: PRTA)

35.99 -1.55 (-4.13%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PRTA $35.99 -4.13%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $37.00
Previous Close $37.54
Daily Range $35.84 - $37.43
52-Week Range $16.71 - $45.00
Market Cap $986.1M
P/E Ratio -129.45
Dividend (Yield) $0.00 (0.0%)
Volume 440,314
Average Daily Volume 773,835
Current FY EPS -$2.59

Sector

Industry

Prothena Corporation (PRTA) Description

Prothena Corporation plc - Ordinary Shares Website: http://www.prothena.com/

News & Commentary

3 Little-Known Biotechs Working On Potential Blockbusters

These three biotechs have promising drugs in their pipelines that address billion dollar drug markets.

Prothena (PRTA) Stock Declines Today on Pricing of Secondary Offering

Heavy Early Morning Activity On Prothena (PRTA)

Too Many Secondaries In Biotech - Cramer's Lightning Round (4/6/15)

Can the Uptrend Continue for Prothena (PRTA)? - Tale of the Tape

The Zacks Analyst Blog Highlights: Biogen, Prothena, Vertex, Gilead and Amgen - Press Releases

This Tiny Biotech Offers Up New Hope for Parkinson's Disease Patients

Phase 1 trial results for Prothena Corporation's PRX-002 could indicate that this drug may help treat Parkinson's disease someday.

How Big Will The Biotech Bubble Get?

Prothena (PRTA) Is Today's Perilous Reversal Stock

Jim Cramer's Top Takeaways: Papa Murphy's, Nike, Prothena

See More PRTA News...